GUSELKUMAB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 11,736 adverse event reports in the FDA FAERS database where GUSELKUMAB was used for Psoriasis.
Most Reported Side Effects for GUSELKUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 9,267 | 33.1% | 2 | 78 |
| Accidental exposure to product | 2,941 | 10.5% | 0 | 16 |
| Drug ineffective | 1,971 | 7.0% | 8 | 61 |
| Needle issue | 1,933 | 6.9% | 0 | 9 |
| Psoriasis | 1,817 | 6.5% | 4 | 115 |
| Device issue | 1,613 | 5.8% | 0 | 7 |
| Device malfunction | 1,410 | 5.0% | 0 | 4 |
| Off label use | 1,186 | 4.2% | 8 | 90 |
| Product storage error | 1,017 | 3.6% | 1 | 11 |
| Inappropriate schedule of product administration | 830 | 3.0% | 1 | 21 |
| Device deployment issue | 778 | 2.8% | 0 | 4 |
| Pneumonia | 767 | 2.7% | 21 | 273 |
| Device leakage | 712 | 2.5% | 0 | 2 |
| Arthralgia | 709 | 2.5% | 1 | 32 |
| Drug delivery system malfunction | 686 | 2.5% | 0 | 9 |
Other Indications for GUSELKUMAB
Product used for unknown indication (12,308)
Psoriatic arthropathy (3,380)
Colitis ulcerative (384)
Crohn's disease (286)
Rheumatoid arthritis (149)
Palmoplantar pustulosis (72)
Arthritis (64)
Pustular psoriasis (60)
Hidradenitis (51)
Ankylosing spondylitis (41)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)
HUMIRA (6,346)